Correlation Between GlaxoSmithKline PLC and WALMART
Specify exactly 2 symbols:
By analyzing existing cross correlation between GlaxoSmithKline PLC ADR and WALMART INC 65, you can compare the effects of market volatilities on GlaxoSmithKline PLC and WALMART and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in GlaxoSmithKline PLC with a short position of WALMART. Check out your portfolio center. Please also check ongoing floating volatility patterns of GlaxoSmithKline PLC and WALMART.
Diversification Opportunities for GlaxoSmithKline PLC and WALMART
0.78 | Correlation Coefficient |
Poor diversification
The 3 months correlation between GlaxoSmithKline and WALMART is 0.78. Overlapping area represents the amount of risk that can be diversified away by holding GlaxoSmithKline PLC ADR and WALMART INC 65 in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on WALMART INC 65 and GlaxoSmithKline PLC is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on GlaxoSmithKline PLC ADR are associated (or correlated) with WALMART. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of WALMART INC 65 has no effect on the direction of GlaxoSmithKline PLC i.e., GlaxoSmithKline PLC and WALMART go up and down completely randomly.
Pair Corralation between GlaxoSmithKline PLC and WALMART
Considering the 90-day investment horizon GlaxoSmithKline PLC ADR is expected to under-perform the WALMART. In addition to that, GlaxoSmithKline PLC is 1.41 times more volatile than WALMART INC 65. It trades about 0.0 of its total potential returns per unit of risk. WALMART INC 65 is currently generating about 0.0 per unit of volatility. If you would invest 11,677 in WALMART INC 65 on August 27, 2024 and sell it today you would lose (206.00) from holding WALMART INC 65 or give up 1.76% of portfolio value over 90 days.
Time Period | 3 Months [change] |
Direction | Moves Together |
Strength | Significant |
Accuracy | 96.77% |
Values | Daily Returns |
GlaxoSmithKline PLC ADR vs. WALMART INC 65
Performance |
Timeline |
GlaxoSmithKline PLC ADR |
WALMART INC 65 |
GlaxoSmithKline PLC and WALMART Volatility Contrast
Predicted Return Density |
Returns |
Pair Trading with GlaxoSmithKline PLC and WALMART
The main advantage of trading using opposite GlaxoSmithKline PLC and WALMART positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if GlaxoSmithKline PLC position performs unexpectedly, WALMART can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in WALMART will offset losses from the drop in WALMART's long position.GlaxoSmithKline PLC vs. Novartis AG ADR | GlaxoSmithKline PLC vs. AstraZeneca PLC ADR | GlaxoSmithKline PLC vs. Roche Holding Ltd | GlaxoSmithKline PLC vs. Bristol Myers Squibb |
WALMART vs. Beyond Meat | WALMART vs. SNDL Inc | WALMART vs. Zhihu Inc ADR | WALMART vs. Getty Images Holdings |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Sign In To Macroaxis module to sign in to explore Macroaxis' wealth optimization platform and fintech modules.
Other Complementary Tools
Competition Analyzer Analyze and compare many basic indicators for a group of related or unrelated entities | |
Latest Portfolios Quick portfolio dashboard that showcases your latest portfolios | |
Premium Stories Follow Macroaxis premium stories from verified contributors across different equity types, categories and coverage scope | |
Companies Directory Evaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals | |
Odds Of Bankruptcy Get analysis of equity chance of financial distress in the next 2 years |